Cerberus Research LabsAmerican-run from Asia / US combat veteran owned and operated
Semaglutide is a long-acting GLP-1 receptor agonist peptide. It is studied in metabolic, incretin, and glucose-signaling research models and is offered strictly as a research-use-only catalog material for laboratory investigation only.
Research Use Only. No clinical, diagnostic, human, or veterinary use.
Shipping to New Zealand
Delivered to New Zealand in 7–21 business days via air freight from Shenzhen, then New Zealand Post. Flat $35 shipping (≈NZ$58) under $500 — free at $500+ (≈NZ$835).
Prices shown in NZD are approximate and for display only; Stripe charges in USD. You are the importer of record and shipments may be assessed by the New Zealand Customs Service.
Certificate of Analysis available per lot — browse the COA library. Research Use Only: not for human or veterinary use.
Semaglutide is a long-acting GLP-1 receptor agonist peptide. It is studied in metabolic, incretin, and glucose-signaling research models and is offered strictly as a research-use-only catalog material for laboratory investigation only. Any discussion of future applications is hypothetical and should not be interpreted as human or veterinary use guidance.
Research discussion focuses on pathway signaling and assay behavior in controlled laboratory models, not human outcomes or dosing.
Current literature and supplier documentation are reviewed in the context of compound identity, lot consistency, assay suitability, and controlled research workflow design.
Any future application discussion is hypothetical, non-promotional, and not clinical guidance. This listing is restricted to laboratory research-use-only review.
Reference placeholders can be added after legal and scientific review. Do not treat this catalog page as medical or regulatory advice.
COA / lot documentation available by request. Use contact/support notes to ask for COA, lot report, or supplier notes.
RUO
Tirzepatide is being researched for its role in GLP-1 and GIP signaling pathways within metabolic, appetite-signaling, and glucose-regulation research models.
RUO
Retatrutide is being researched for its role in GLP-1, GIP, and glucagon signaling pathways within metabolic and body-composition research models.
RUO
Cagrilintide is being researched within metabolic research, appetite signaling, glucose regulation as a research-use-only catalog material for qualified laboratory and analytical workflows.
RUO
Semaglutide is a long-acting GLP-1 receptor agonist peptide. It is studied in metabolic, incretin, and glucose-signaling research models and is offered strictly as a research-use-only catalog material for laboratory investigation only.